nach oben

Current Diabetes Reports

Erschienen in:

24.11.2023 | REVIEW

Obesity and Severity of Menopausal Symptoms: a Contemporary Review

verfasst von: Vivian Cao, Alisha Clark, Brooke Aggarwal

Erschienen in: Current Diabetes Reports | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Vasomotor symptoms are frequently experienced by women during menopause and have been linked to obesity. Severity of menopausal symptoms is a distinct construct from presence of symptoms, and the relation between severity of symptoms and obesity is less established. The purpose of this brief narrative review was to summarize evidence from recent studies on associations between menopausal symptom severity and measures of obesity.

Recent Findings

Sixteen articles were identified that specifically assessed and reported on the severity of menopausal symptoms in relation to measures of obesity including body mass index (BMI), waist circumference, and waist-to-hip ratio.

Summary

Most studies to date show that greater BMI, waist size, and waist-to-hip ratio are associated with greater severity of menopausal symptoms. Given the large segment of women who will experience symptoms and that severity of symptoms influences treatment decisions, future studies are needed to determine how weight management efforts may reduce the severity of menopausal symptoms.

Woods NF, Mitchell ES. Symptoms during the perimenopause: Prevalence, severity, trajectory, and significance in women’s lives. Am J Med. 2005;118(Suppl 12B):14–24. https://doi.org/10.1016/j.amjmed.2005.09.031.CrossRefPubMed

Guthrie JR, Dennerstein L, Taffe JR, Donnelly V. Health care-seeking for menopausal problems. Climacteric. 2003;6(2):112–7.CrossRefPubMed

Santoro N. Perimenopause: From research to practice. J Womens Health. 2016;25(4):332–9. https://doi.org/10.1089/jwh.2015.5556.CrossRef

Thurston RC, Joffe H. Vasomotor symptoms and menopause: Findings from the Study of Women’s Health across the Nation. Obstet Gynecol Clin North Am. 2011;38(3):489–501. https://doi.org/10.1016/j.ogc.2011.05.006.CrossRefPubMedPubMedCentral

ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol. 2014;123(1):202–16. https://doi.org/10.1097/01.AOG.0000441353.20693.78.CrossRef

Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531–9. https://doi.org/10.1001/jamainternmed.2014.8063.CrossRefPubMedPubMedCentral

Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review. Health Qual Life Outcomes. 2005;3:47. https://doi.org/10.1186/1477-7525-3-47.CrossRefPubMedPubMedCentral

Muka T, Oliver-Williams C, Colpani V, Kunutsor S, Chowdhury S, Chowdhury R, et al. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: A systematic review and meta-analysis. PLoS ONE. 2016;11(6):e0157417. https://doi.org/10.1371/journal.pone.0157417.CrossRefPubMedPubMedCentral

Johnson A, Roberts L, Elkins G. Complementary and alternative medicine for menopause. J Evid Based Integr Med. 2019;24:2515690X19829380. https://doi.org/10.1177/2515690X19829380.CrossRefPubMedPubMedCentral

10.

Freeman EW, Sammel MD, Lin H, Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause. 2010;17(4):718–26. https://doi.org/10.1097/gme.0b013e3181cec85d.CrossRefPubMedPubMedCentral

11.

Karvonen-Gutierrez C, Kim C. Association of mid-life changes in body size, body composition and obesity status with the menopausal transition. Healthcare. 2016;4(3):42. https://doi.org/10.3390/healthcare4030042.CrossRefPubMedPubMedCentral

12.

Koo S, Ahn Y, Lim JY, Cho J, Park HY. Obesity associates with vasomotor symptoms in postmenopause but with physical symptoms in perimenopause: A cross-sectional study. BMC Womens Health. 2017;17(1):126. https://doi.org/10.1186/s12905-017-0487-7.CrossRefPubMedPubMedCentral

13.

Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: A Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16(3):177–89. https://doi.org/10.1038/s41574-019-0310-7.CrossRefPubMedPubMedCentral

14.

Stefanska A, Bergmann K, Sypniewska G. Metabolic syndrome and menopause: Pathophysiology, clinical and diagnostic significance. Adv Clin Chem. 2015;72:1–75. https://doi.org/10.1016/bs.acc.2015.07.001.CrossRefPubMed

15.

Fang H, Berg E, Cheng X, Shen W. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018;21(5):360–5. https://doi.org/10.1097/MCO.0000000000000485.CrossRefPubMedPubMedCentral

16.

Gold EB, Crawford SL, Shelton JF, Tepper PG, Crandall CJ, Greendale GA, et al. Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: The Study of Women’s Health Across the Nation (SWAN). Menopause. 2017;24(1):9–26. https://doi.org/10.1097/GME.0000000000000723.CrossRefPubMedPubMedCentral

17.

Proietto J. Obesity and weight management at menopause. Aust Fam Phys. 2017;46(6):368–70.

18.

Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes. 2003;1:28. https://doi.org/10.1186/1477-7525-1-28.CrossRefPubMedPubMedCentral

19.

Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version. MENQOL-Interven Questionnaire Maturitas. 2005;50(3):209–21. https://doi.org/10.1016/j.maturitas.2004.06.015.CrossRefPubMed

20.

Sarrel P. Evaluation and management of postmenopausal patients. Female Patient. 1995;20(Suppl 2):27–32.

21.

Tao M, Shao H, Li C, Teng Y. Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women. Patient Prefer Adherence. 2013;7:223–9. https://doi.org/10.2147/PPA.S42852.CrossRefPubMedPubMedCentral

22.

Schneider HP, Heinemann LA, Rosemeier HP, Potthoff P, Behre HM. The Menopause Rating Scale (MRS): Comparison with Kupperman index and quality-of-life scale SF-36. Climacteric. 2000;3(1):50–8. https://doi.org/10.3109/13697130009167599.CrossRefPubMed

23.

Lima JE, Palacios S, Wender MC. Quality of life in menopausal women: A Brazilian Portuguese version of the Cervantes Scale. Sci World J. 2012;2012:620519. https://doi.org/10.1100/2012/620519.CrossRef

24.

Taşkıran G, Özgül S. Individual characteristics associated with menopausal symptom severity and menopause-specific quality of life: A rural perspective. Reprod Sci. 2021;28(9):2661–71. https://doi.org/10.1007/s43032-021-00545-y.CrossRefPubMed

25.

Costa JG, Rodrigues RM, Puga GM, Cheik NC. Does obesity aggravate climacteric symptoms in postmenopausal women? Rev Bras Ginecol Obstet. 2022;44(6):586–92. https://doi.org/10.1055/s-0042-1745789.CrossRefPubMedPubMedCentral

26.

Kim GD, Chun H, Doo M. Associations among BMI, dietary macronutrient consumption, and climacteric symptoms in Korean menopausal women. Nutrients. 2020;12(4):945. https://doi.org/10.3390/nu12040945.CrossRefPubMedPubMedCentral

27.

He Y, Tian J, Oddy WH, Blizzard L, Dwyer T, Hickey M, et al. The associations of childhood adiposity with menopausal symptoms in women aged 45–49 years: An Australian Cohort Study. Maturitas. 2021;143:81–8. https://doi.org/10.1016/j.maturitas.2020.09.008.CrossRefPubMed

28.

Singhania K, Kalhan M, Choudhary P, Kumar T. Association of menopausal symptoms with overweight and obesity among rural middle aged women in North India: A population based study. J Midlife Health. 2020;11(3):137–43. https://doi.org/10.4103/jmh.JMH_123_19.CrossRefPubMedPubMedCentral

29.

Tang R, Fan Y, Luo M, Zhang D, Xie Z, Huang F, et al. General and central obesity are associated with increased severity of the VMS and sexual symptoms of menopause among Chinese women: A longitudinal study. Front Endocrinol. 2022;13:814872. https://doi.org/10.3389/fendo.2022.814872.CrossRef

30.

El Hajj A, Wardy N, Haidar S, Bourgi D, Haddad ME, Chammas DE, et al. Menopausal symptoms, physical activity level and quality of life of women living in the Mediterranean region. PLoS ONE. 2020;15(3):e0230515. https://doi.org/10.1371/journal.pone.0230515.CrossRefPubMedPubMedCentral

31.

Sreenivas SB, Kashyap PB. Effects of obesity on severity of menopausal symptoms in urban and rural women. J Midlife Health. 2022;13(4):304–9. https://doi.org/10.4103/jmh.jmh_220_22.CrossRefPubMed

32.

Anderson DJ, Chung HF, Seib CA, Dobson AJ, Kuh D, Brunner EJ, et al. Obesity, smoking, and risk of vasomotor menopausal symptoms: A pooled analysis of eight cohort studies. Am J Obstet Gynecol. 2020;222(5):478.e1-e17. https://doi.org/10.1016/j.ajog.2019.10.103.CrossRefPubMed

33.

Kazama M, Terauchi M, Odai T, Kato K, Miyasaka N. Associations of fat mass index with hot flashes and lean mass index with insomnia in middle-aged women. Climacteric. 2023;26(2):161–6. https://doi.org/10.1080/13697137.2023.2173566.CrossRefPubMed

34.

Zhou Y, Zheng Y, Li C, Hu J, Geng L, Tao M. Association of body composition with menopausal symptoms in (peri-)menopausal women. Climacteric. 2018;21(2):179–83. https://doi.org/10.1080/13697137.2018.1428295.CrossRefPubMed

35.

Hybholt M. Psychological and social health outcomes of physical activity around menopause: A scoping review of research. Maturitas. 2022;164:88–97. https://doi.org/10.1016/j.maturitas.2022.07.014.CrossRefPubMed

36.

Stojanovska L, Apostolopoulos V, Polman R, Borkoles E. To exercise, or, not to exercise, during menopause and beyond. Maturitas. 2014;77(4):318–23. https://doi.org/10.1016/j.maturitas.2014.01.006.CrossRefPubMed

37.

Szuscik-Niewiadomy K, Plinta R, Niewiadomy P, Knapik A. Past physical activity and its influence on female functioning during perimenopause. Ginekol Pol. 2021;92(5):352–8. https://doi.org/10.5603/GP.a2021.0028.CrossRefPubMed

38.

Wu S, Shi Y, Zhao Q, Men K. The relationship between physical activity and the severity of menopausal symptoms: A cross-sectional study. BMC Womens Health. 2023;23(1):212. https://doi.org/10.1186/s12905-023-02347-7.CrossRefPubMedPubMedCentral

39.

Dąbrowska-Galas M, Dąbrowska J, Ptaszkowski K, Plinta R. High physical activity level may reduce menopausal symptoms. Medicina. 2019;55(8):466. https://doi.org/10.3390/medicina55080466.CrossRefPubMedPubMedCentral

40.

Javadivala Z, Allahverdipour H, Asghari Jafarabadi M, Emami A. An interventional strategy of physical activity promotion for reduction of menopause symptoms. Health Promot Perspect. 2020;10(4):383–92. https://doi.org/10.34172/hpp.2020.57.CrossRefPubMedPubMedCentral

41.

Kim B, Kang S. Regular leisure-time physical activity is effective in boosting neurotrophic factors and alleviating menopause symptoms. Int J Environ Res Public Health. 2020;17(22):8624. https://doi.org/10.3390/ijerph17228624.CrossRefPubMedPubMedCentral

42.

Jung SY, Vitolins MZ, Fenton J, Frazier-Wood AC, Hursting SD, Chang S. Risk profiles for weight gain among postmenopausal women: A classification and regression tree analysis approach. PLoS ONE. 2015;10(3):e0121430. https://doi.org/10.1371/journal.pone.0121430.CrossRefPubMedPubMedCentral

43.

Brown LM, Clegg DJ. Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol. 2010;122(1–3):65–73. https://doi.org/10.1016/j.jsbmb.2009.12.005.CrossRefPubMed

44.

El Khoudary SR, Greendale G, Crawford SL, Avis NE, Brooks MM, Thurston RC, et al. The menopause transition and women’s health at midlife: A progress report from the Study of Women’s Health Across the Nation (SWAN). Menopause. 2019;26(10):1213–27. https://doi.org/10.1097/GME.0000000000001424.CrossRefPubMedPubMedCentral

45.

Chung HF, Zhu D, Dobson AJ, Kuh D, Gold EB, Crawford SL, et al. Age at menarche and risk of vasomotor menopausal symptoms: A pooled analysis of six studies. BJOG. 2021;128(3):603–13. https://doi.org/10.1111/1471-0528.16393.CrossRefPubMed

46.

Opoku AA, Abushama M, Konje JC. Obesity and menopause. Best Pract Res Clin Obstet Gynaecol. 2023;88:102348. https://doi.org/10.1016/j.bpobgyn.2023.102348.CrossRefPubMed

47.

Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care. 2004;7(4):405–10. https://doi.org/10.1097/01.mco.0000134362.76653.b2.CrossRefPubMedPubMedCentral

Titel: Obesity and Severity of Menopausal Symptoms: a Contemporary Review
verfasst von: Vivian Cao
Alisha Clark
Brooke Aggarwal
Publikationsdatum: 24.11.2023
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 12/2023
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-023-01528-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Obesity and Severity of Menopausal Symptoms: a Contemporary Review

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin